170 related articles for article (PubMed ID: 27788496)
1. Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin.
Xue D; Zhou C; Shi Y; Lu H; Xu R; He X
Oncotarget; 2016 Nov; 7(48):78804-78812. PubMed ID: 27788496
[TBL] [Abstract][Full Text] [Related]
2. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.
Chen Y; Zhang Z; Yang K; Du J; Xu Y; Liu S
Oncogene; 2015 Jul; 34(29):3839-47. PubMed ID: 25284586
[TBL] [Abstract][Full Text] [Related]
3. Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer.
Deng Z; Manz DH; Torti SV; Torti FM
Antioxid Redox Signal; 2019 Mar; 30(8):1043-1061. PubMed ID: 29061069
[TBL] [Abstract][Full Text] [Related]
4. Disordered signaling governing ferroportin transcription favors breast cancer growth.
Chen Y; Zhang S; Wang X; Guo W; Wang L; Zhang D; Yuan L; Zhang Z; Xu Y; Liu S
Cell Signal; 2015 Jan; 27(1):168-76. PubMed ID: 25451081
[TBL] [Abstract][Full Text] [Related]
5. Silencing of PYGB suppresses growth and promotes the apoptosis of prostate cancer cells via the NF‑κB/Nrf2 signaling pathway.
Wang Z; Han G; Liu Q; Zhang W; Wang J
Mol Med Rep; 2018 Oct; 18(4):3800-3808. PubMed ID: 30106110
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.
Jiang X; Zhang C; Qi S; Guo S; Chen Y; Du E; Zhang H; Wang X; Liu R; Qiao B; Yang K; Zhang Z; Xu Y
Oncotarget; 2016 Dec; 7(51):84893-84906. PubMed ID: 27768596
[TBL] [Abstract][Full Text] [Related]
7. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis.
Yang G; Yin H; Lin F; Gao S; Zhan K; Tong H; Tang X; Pan Q; Gou X
Pathol Res Pract; 2020 Apr; 216(4):152851. PubMed ID: 32057513
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
[TBL] [Abstract][Full Text] [Related]
10. Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling.
Serttas R; Koroglu C; Erdogan S
Anticancer Agents Med Chem; 2021; 21(3):372-382. PubMed ID: 32781972
[TBL] [Abstract][Full Text] [Related]
11. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
13. The role of Nrf2 in migration and invasion of human glioma cell U251.
Pan H; Wang H; Zhu L; Mao L; Qiao L; Su X
World Neurosurg; 2013; 80(3-4):363-70. PubMed ID: 22120303
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.
Wang P; Zou XM; Huang J; Zhang TL; Wang K
Cell Biol Int; 2011 Nov; 35(11):1159-67. PubMed ID: 21605080
[TBL] [Abstract][Full Text] [Related]
15. Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231.
Meng C; Song L; Wang J; Li D; Liu Y; Cui X
Oncol Rep; 2017 Feb; 37(2):841-848. PubMed ID: 28035403
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.
Song X; Wang Y; Du H; Fan Y; Yang X; Wang X; Wu X; Luo C
Prostate; 2014 Jul; 74(10):1023-33. PubMed ID: 24811146
[TBL] [Abstract][Full Text] [Related]
17. Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element.
Qian Y; Yin C; Chen Y; Zhang S; Jiang L; Wang F; Zhao M; Liu S
Cell Signal; 2015 May; 27(5):934-42. PubMed ID: 25660146
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells.
Pettazzoni P; Ciamporcero E; Medana C; Pizzimenti S; Dal Bello F; Minero VG; Toaldo C; Minelli R; Uchida K; Dianzani MU; Pili R; Barrera G
Free Radic Biol Med; 2011 Oct; 51(8):1610-8. PubMed ID: 21816220
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-153 Regulates NRF2 Expression and is Associated with Breast Carcinogenesis.
Wang B; Teng Y; Liu Q
Clin Lab; 2016; 62(1-2):39-47. PubMed ID: 27012032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
